SCHEMBL8669690

SCHEMBL8669690

CCCCc1cccc2c1C(C(=O)N(CCC)N1CCC(NC(=O)c3ccccc3)C1)c1ccccc1-2

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ UTS2R Q9UKP6 1/20 0.39
▸ NPSR1 Q6W5P4 1/20 0.39
▸ CTSL P07711 1/20 0.37
▸ CTSB P07858 1/20 0.37
▸ CTSK P43235 1/20 0.37
▸ POLB P06746 2/20 0.36
▸ DRD2 P14416 6/20 0.36
▸ DRD4 P21917 6/20 0.36
▸ CHRM1 P11229 2/20 0.36
▸ CARM1 Q86X55 1/20 0.36
▸ PRMT6 Q96LA8 1/20 0.36
▸ KMT2A Q03164 2/20 0.35
▸ ADRA1D P25100 1/20 0.35
▸ ADRA1A P35348 1/20 0.35
▸ ADRA1B P35368 1/20 0.35
▸ MCHR1 Q99705 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ MEN1 O00255 1/20 0.34
▸ GAA P10253 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8714746 0.95 CHRM1 (0.38) UTS2RNPSR1CTSLCTSBCTSK
SCHEMBL8502242 0.93 NPSR1 (0.35) UTS2RNPSR1POLBCHRM1CARM1
SCHEMBL8665883 0.91 NPSR1 (0.37) UTS2RNPSR1CTSLCTSBCTSK
SCHEMBL8666099 0.88 NPSR1 (0.36) UTS2RNPSR1CTSLCTSBCTSK
SCHEMBL8485545 0.86 NPSR1 (0.40) NPSR1POLBCARM1PRMT6KMT2A
SCHEMBL8501239 0.84 NPSR1 (0.33) UTS2RNPSR1POLBDRD2DRD4
SCHEMBL8484461 0.83 NPSR1 (0.39) NPSR1POLBCARM1PRMT6KMT2A
SCHEMBL8501052 0.82 NPSR1 (0.33) NPSR1POLBDRD2DRD4CHRM1
SCHEMBL8668077 0.81 OPRK1 (0.32) DRD2
SCHEMBL8665520 0.80 CCR3 (0.42) NPSR1DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5827875-A PYRROLIDINE DERIVATIVES; ANTIATHEROSCLEROSIS AGENTS BRISTOL-MYERS SQUIBB COMPANY (US) 1998-10-27 — — US disclosed
Send feedback